Amy Hitchler
Addiction Medicine · Westerville, OHNPI 1790251114
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,749 and has fallen 97.1% since, to $78 in 2024.
Across 246 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$901
- Pfizer$524
- Amarin Pharma, Inc.$474
- Novo Nordisk$365
- GSK$286
- AbbVie$282
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,890100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $901 |
| Pfizer | 36 | $524 |
| Amarin Pharma, Inc. | 35 | $474 |
| Novo Nordisk | 34 | $365 |
| GSK | 14 | $286 |
| AbbVie | 17 | $282 |
| Biohaven Pharmaceuticals, Inc. | 12 | $179 |
| Bayer | 5 | $146 |
| Boehringer Ingelheim | 10 | $137 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $90 |
| Lilly USA, LLC | 5 | $79 |
| Dexcom, Inc. | 5 | $73 |
| Merck | 3 | $63 |
| Novartis | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| SK Life Science, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,897 in reported general payments places this provider in the 85th percentile of 98 addiction medicine providers in Ohio.
Other addiction medicine in Westerville
- Parag PatelCincinnati$171K
- Stephanie TraylorColumbus$86K
- Wayne KawalekOakwood Village$82K
- Nicole LaborAkron$17K
- Orman HallColumbus$10K
- Puja SrivastavaWilmington$9K
- David KesegChillicothe$8K
- Timothy SuttonMansfield$6K
- Robert MasoneColumbus$6K
- Abdullahi MubarakCenterville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.